Comparative Pharmacology
Head-to-head clinical analysis: AMINOSYN PF 10 versus CLINIMIX E 2 75 10 SULFITE FREE W ELECT IN DEXTROSE 10 W CALCIUM IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMINOSYN PF 10 versus CLINIMIX E 2 75 10 SULFITE FREE W ELECT IN DEXTROSE 10 W CALCIUM IN PLASTIC CONTAINER.
AMINOSYN-PF 10% vs CLINIMIX E 2.75/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Aminosyn-PF 10% is a crystalline amino acid solution that provides essential and non-essential amino acids for protein synthesis and nitrogen balance in neonates and pediatric patients.
CLINIMIX E 2.75/10 is a parenteral nutrition solution providing amino acids, dextrose, electrolytes, and calcium. Amino acids serve as substrates for protein synthesis, dextrose provides caloric energy, and electrolytes maintain fluid and electrolyte balance.
Intravenous infusion: 1-1.5 g amino acids/kg/day (protein equivalent) as part of total parenteral nutrition. Typical rate: 0.5-2.0 mL/kg/hour initially, titrated to metabolic needs.
Intravenous infusion. Adult dose: 1-2 L per day, administered at a rate not exceeding 100 mL/hour initially, then adjusted based on metabolic and fluid requirements. Each liter contains amino acids 27.5 g, dextrose 100 g, and electrolytes including calcium.
None Documented
None Documented
Variable; amino acids have half-lives of minutes to hours; clinical context: continuous infusion maintains steady state
Not applicable as a fixed combination product; individual components have half-lives: amino acids ~0.5-2 h, dextrose ~2-4 h, electrolytes vary (e.g., calcium ~2-4 h).
Renal: >90% as amino acids and metabolites; <10% fecal/biliary
Renal excretion of infused amino acids and electrolytes; glucose is metabolized to CO2 and water; 100% of water and electrolytes excreted renally.
Category C
Category C
Parenteral Nutrition Solution
Parenteral Nutrition Solution